South Korean gold funds exhibited three-month average returns of 10.22 percent, far outperforming the median return rate for domestic stock funds of minus 12.16 percent.
The FnGuide, a financial information provider, attributed the gold funds' solid performance to a bump in gold prices as investors are increasingly turning to safe assets during the coronavirus scare.
The FnGuide noted that the price of one gram of gold closed at 68,860 won on the domestic market on April 24, its highest since the market opened in March 2014.
In contrast, South Korea's oil funds have been sliding during the said period on the as pandemic sent crude prices plummeting. Two of the country's major oil commodity exchange-traded funds (ETFs), had an average return of minus 64 percent to 74 percent.
Sinking demand brought about by the outbreak, and failure to agree on a production cut among major producers were attributed as the reason behind plunging international oil prices.


American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
European Stocks Rally on Chinese Growth and Mining Merger Speculation
Investors Brace for Market Moves as Trump Begins Second Term
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Home ownership is slipping out of reach. It’s time to rethink our fear of ‘forever renting’
Mexico's Undervalued Equity Market Offers Long-Term Investment Potential
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
U.S. Banks Report Strong Q4 Profits Amid Investment Banking Surge
South Korea to End Short-Selling Ban as Financial Market Uncertainty Persists
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Elliott Investment Management Takes Significant Stake in BP to Push for Value Growth
U.S. Condemns China's Dominance in Global Shipbuilding and Maritime Sectors
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 



